CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,138,950
- in 5 filings, $4.8M under 10b5-1 plans
Net −$7,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-21 | Howe Jolanda SVP, GLOBAL CONTROLLER | Grant or award · Stock Option (right to buy) | +18,500 | 18,500 | ||
| 2025-01-21 | Howe Jolanda SVP, GLOBAL CONTROLLER | Grant or award · Restricted Stock Units | +4,625 | 4,625 | ||
| 2025-01-21 | Howe Jolanda SVP, GLOBAL CONTROLLER | Grant or award · Performance Restricted Stock Units | +7,973 | 7,973 | ||
| 2025-01-21 | Quan Joanne CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-01-21 | Quan Joanne CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2025-01-21 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-01-21 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2025-01-21 | Radovich Peter PRESIDENT AND COO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-01-21 | Radovich Peter PRESIDENT AND COO | Grant or award · Restricted Stock Units | +12,500 | 12,500 | ||
| 2025-01-21 | Radovich Peter PRESIDENT AND COO | Grant or award · Performance Restricted Stock Units | +21,660 | 21,660 | ||
| 2025-01-21 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +153,550 | 153,550 | ||
| 2025-01-21 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +38,390 | 38,390 | ||
| 2025-01-21 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Grant or award · Performance Restricted Stock Units | +75,000 | 75,000 | ||
| 2025-01-17 | Quan Joanne CHIEF MEDICAL OFFICER | Sale | −6,969 | $45.86 | $320K | 5,649 |
| 2025-01-16 | Quan Joanne CHIEF MEDICAL OFFICER | Option exercise | +12,500 | 12,618 | ||
| 2025-01-16 | Quan Joanne CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −12,500 | 25,000 | ||
| 2025-01-07 | Radovich Peter PRESIDENT AND COO | Sale | −1,998 | $42.82 | $86K | 27,015 |
| 2025-01-07 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale | −7,489 | $42.82 | $321K | 119,359 |
| 2025-01-07 | Howe Jolanda SVP, GLOBAL CONTROLLER | Sale | −750 | $42.82 | $32K | 2,926 |
| 2025-01-06 | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise | +1,250 | 3,676 |
Page 16 of 25 · 490 trades